Cardinal Health Inc. Common Stock (CAH)
Stock · NYSE · Health Care
$254.13as of 10/16/2026
Price chart
Active signals
CAH Signal Track Record
How signals performed across all stocks →What CAH's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 30 | +2.6% | 67% | September 18, 2026 |
| Bollinger Band BreakoutActive now | 29 | +4.7% | 86% | September 2, 2026 |
| Bollinger Band Breakdown | 17 | +0.9% | 59% | July 22, 2026 |
| 200-Day Moving Average TouchActive now | 7 | +2.2% | 86% | August 2, 2024 |
| Any 20-session window (baseline) | +2.0% | 61% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It…
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
- Employees
- 58,788
Fundamentals
- 1-day range
- $251.95$255.55
- Market cap
- $55.66B
- P/E (trailing)
- 33.97
- P/E (forward)
- 18.07
- EPS (trailing)
- $7.24
- Dividend yield
- 1.88%
- Beta
- 0.55
- Avg. volume
- 1.79M
- Ex-dividend date
- October 1, 2026
- Dividend pay date
- October 15, 2026
How Cardinal Health Inc. Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Aug 11, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Cardinal Health Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- CAHCardinal Health Inc. Common Stock$254.06▲ 0.14%Market cap $55.66BP/E 33.97$152.46$258.3
- CORCencora Inc. Common Stock$340.92▼ 0.14%Market cap $63.23BP/E 24.39$244.82$377.54
- MCKMcKesson Corporation Common Stock$1,005▲ 0.62%Market cap $104.74BP/E 25.30$723.68$999
- HLFHerbalife Ltd. Common Shares$14.6▲ 0.21%Market cap $1.19BP/E 9.24$7.56$20.4
- NUSNu Skin Enterprises Inc. Common Stock$5.14▼ 1.34%Market cap $251.98MP/E 4.30$4.45$11.67
- ZSTKZeroStack Corp. Common Stock$4▼ 5.21%Market cap $30.78MP/E —$1.32$20.45
- HKPDCellyan Biotechnology Co. Ltd Class A Ordinary Shares$0.11▲ 0.00%Market cap $16.93MP/E —$0.095$1.72
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CAH Cardinal Health Inc. Common Stock | $55.66B | 33.97 | $254.06 | ▲ 0.14% | $152.46$258.3 |
| COR Cencora Inc. Common Stock | $63.23B | 24.39 | $340.92 | ▼ 0.14% | $244.82$377.54 |
| MCK McKesson Corporation Common Stock | $104.74B | 25.30 | $1,005 | ▲ 0.62% | $723.68$999 |
| HLF Herbalife Ltd. Common Shares | $1.19B | 9.24 | $14.6 | ▲ 0.21% | $7.56$20.4 |
| NUS Nu Skin Enterprises Inc. Common Stock | $251.98M | 4.30 | $5.14 | ▼ 1.34% | $4.45$11.67 |
| ZSTK ZeroStack Corp. Common Stock | $30.78M | — | $4 | ▼ 5.21% | $1.32$20.45 |
| HKPD Cellyan Biotechnology Co. Ltd Class A Ordinary Shares | $16.93M | — | $0.11 | ▲ 0.00% | $0.095$1.72 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- UBS Maintains Buy on Cardinal Health, Raises Price Target to $295benzinga · 10/16/2026
- Dividend Champion, Contender, And Challenger Highlights: Week October 11SeekingAlpha · 10/9/2026
- What Does CVS Health (CVS) Gain From Extending Its Drug Distribution Deals To 2032?Yahoo · 10/8/2026
- Reasons to Retain Cardinal Health Stock in Your Portfolio for NowYahoo · 10/6/2026
- Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?Yahoo · 10/6/2026
- CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?Yahoo · 10/6/2026
- 1 Healthcare Stock with Exciting Potential and 2 We Find RiskyYahoo · 10/6/2026
- Cardinal Health (CAH) Outperforms Broader Market: What You Need to KnowYahoo · 10/5/2026
- Disposable Medical Device Market to Reach USD 144.85 Billion by 2030, Growing at a CAGR of 4.9% – MarketsandMarkets™Yahoo · 10/5/2026
Insider Activity
Insider Actions →- Jason M. Hollar · August 19, 2026 · Sale6.2K @ $233.22
- Mary C. Scherer · August 19, 2026 · Sale2.2K @ $237.39
- Mary C. Scherer · August 19, 2026 · Sale100 @ $237.4
- Jason M. Hollar · August 19, 2026 · Sale6.2K @ $237.88
- Jason M. Hollar · August 19, 2026 · Sale16.2K @ $237.23
- Jason M. Hollar · August 19, 2026 · Sale6.7K @ $236.46
- Jason M. Hollar · August 19, 2026 · Sale5.7K @ $235.34
- Jason M. Hollar · August 19, 2026 · Sale3.5K @ $234.29
- Michelle D. Greene · August 18, 2026 · Sale686 @ $237.25
- Michelle D. Greene · August 18, 2026 · Sale3.5K @ $236.31
- Michelle D. Greene · August 18, 2026 · Sale5.0K @ $235.68
- Michelle D. Greene · August 18, 2026 · Sale2.5K @ $234.57
- Deborah Weitzman · August 18, 2026 · Sale281 @ $237.44
- Deborah Weitzman · August 18, 2026 · Sale408 @ $236.59
- Deborah Weitzman · August 18, 2026 · Sale6.7K @ $235.3
Institutional Ownership
March 31, 2026
- Total shares held
- 184.37M
- Total value held
- $36.79B
- Institutional holders
- 1406
- Unknown28.49M
- Unknown15.29M
- Unknown12.07M
- Unknown6.58M
- Unknown4.95M
- Unknown4.28M
- Unknown4.24M
- Unknown4.01M
- Unknown3.51M
- Unknown2.88M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cardinal Health Hits Record Highs as Sector Strength Continues
Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.
Cardinal Health Hits Record Highs as Sector Strength Continues. Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.